GTx is developing new image-guided technologies for advanced therapeutics in surgery, interventional radiology and radiation medicine.
- Available Equipment
- Contacts
- Overview
- Services
- Unique Capacities
- Using the Facility
Dr. Robert Weersink
416-946-4501 (16-5740)
Princess Margaret Cancer Research Tower
110 College St, Room 7-1001
Toronto, Ontario, M5G 2C4
Established in 2006, the Guided Therapeutics Program (GTx) at the University Health Network is a collaboration of surgeons, medical imaging specialists, radiation oncologists, interventional radiologists, physicists, nanotechnology engineers and biomedical engineers all focused on the research, development and clinical implementation of innovative technologies to enable novel cancer diagnostics and therapeutics. The current scope of the program includes research and development in pre-clinical and translational/clinical settings.
The GTx program has coordinated the planning and implementation of image-guided resources across UHN. This includes the GTx-Lab with 1 fully equipped operating room, the GTx-OR and GTx-MR suite at the Toronto General Hospital/UHN.
The facility is led by:
- Dr. Jonathan Irish (surgical oncology)
- Dr. David Jaffray (radiation therapy)
- Dr. Walter Kucharczyk (medical imaging)
- Dr. Kazuhiro Yasufuku (thoracic surgery)
- Dr. Kieran Murphy (interventional radiology)
- Dr. Michael Tymianski (neurosurgery)
- Dr. John Trachtenberg (prostate interventions)
- Dr. Michael Jewett (renal interventions)
Research, development and translation of advanced imaging and guidance technologies in therapeutic interventions, including surgery, radiation therapy and interventional radiology.
Primary focus is on cancer interventions. Mandate is toward creation and translation of new technologies and therapeutic techniques, with a strong emphasis on research.
- Unique multi-disciplinary research collaboration among scientists, engineers and clinicians with a shared vision toward revolutionary cancer interventions
- High-precision, image-guided interventions (including surgery, radiotherapy and cell-based therapies)
Resources are available on a collaborative basis. Research collaborations with physicists, engineers, surgeon scientists, radiation oncologists and other UHN investigators are welcome.
Sample Preparation
Please contact Dr. Robert Weersink (robert.weersink@rmp.uhn.on.ca, 416-946-4501 ) for more information.